Ion Channel Retreat Channel Ion 2014 June Vancouver, Background

• A division of SB Drug Discovery

• Located in Glasgow, Scotland

• Established in 1994

• 25 researchers Overview

• SB Drug Discovery specializes in expression, cell line development and assay services

• Developed > 100 custom cell lines expressing ion channels, GPCRs, antibodies etc

• Developed Nav1.1 – Nav1.8 panel

• Highly experienced electrophysiology team

• SB Ion Channels Division set up in 2013

 Off the shelf cell lines

 Custom ion channel cell line development

 Ion channel screening services SB Ion Channels

• Parallel processing systems put in place to enable efficient development of multiple ion channel cell lines simultaneously

• Last 12 months : 40 ion channel cell lines developed

• Currently offering over 50 ion channel targets

• Further 6 targets in development Voltage gated channels

Sodium Potassium Other Channels Channels Channels Nav1.1 Kv2.1 Kir2.1 Ano1

Nav1.2 Kv2.1 / 9.3 Kir2.2 Ano2

Nav1.3 Kv2.2 Kir2.4

Nav1.4 Kv3.1 SLACK

Nav1.5 Kv3.2 TREK-1

Nav1.6 Kv7.2 TRESK

Nav1.7 Kv7.2/7.3

Nav1.8 Nav1.7 monkey Nav1.7 dog

Nav1.7 rat Ligand gated channels

Purinergic TRP Channels Other Channels Channels

P2X1 TRPA1 TRPV1 TRPM2 TRPC1 NMDA TRPA1 P2X2 TRPV2 TRPM3 TRPC3 monkey TRPA1 P2X3 TRPV3 TRPM4 TRPC4 sheep P2X4 TRPV4 TRPM5 TRPC5

P2X5 TRPV5 TRPM8 TRPC6

P2X6 TRPV6 TRPC7

P2X7 TRPV1 rat

P2X7 mouse TRPV1 dog (transient) Pain related channels

Pain related channels available at SB Nav1.1 TRPV3 TRPC4 Kv7.2/7.3 Nav1.2 TRPV4 TRPC5 TREK-1 Nav1.3 TRPM2 TRPC6 TRESK Nav1.7 TRPM3 P2X1 SLACK Nav1.8 TRPM4 P2X2 Ano1 TRPA1 TRPM8 P2X3 NMDA TRPV1 TRPC1 P2X4 TRPV2 TRPC3 P2X7

Animal variants Dog Nav1.7 Monkey TRPA1 Rat TRPV1 Dog TRPV1 Rat Nav1.7 Sheep TRPA1 (transient) Monkey Nav1.7 Validation

QPatch - voltage gated

Nav1.1 – Nav1.8 TREK-1 TRESK

Kv3.1 Ano 1 Ano 2 Validation

QPatch – ligand gated

TRPM4 TRPM5 TRPA1 TRPA1 (monkey)

Awaiting data analysis

TRPV1 TRPV3 TRPV4 TRP channels

• 22 TRP channels

TRPA1 TRPA1 (monkey) TRPA1 (sheep) TRPC1 TRPC3 TRPC4 TRPC5 TRPC6 TRPC7 TRPM2 TRPM3 TRPM4 TRPM5 TRPM8 TRPV1 TRPV2 TRPV3 TRPV4 TRPV5 TRPV6 TRPV1 (rat) TRPV1 (dog)

• Customized selectivity panels

• Flexstation assay or manual patch clamp assessment

• Ongoing development of single use, assay ready cells for custom selectivity kits Moving forward

Development of 30 new ion channel cell lines

Targets selected based on client feedback

Optimized cell lines for QPatch & IonWorks

Custom Cell Line Development

• Conventional cell line development process

• Risk-free development

• Gene synth, subcloning, mutagenesis Molecular • Sequence analysis Milestone 1 Biology

Deliverable – sequence validated expression plasmid • Transfection, clonal selection Cell • Single cell colony growth Biology

• Colony screening • Detailed electrophysiology assessment Validation • Stability, mycoplasma, stock generation

Milestone 2

Deliverable – Functionally validated stable cell line (defined criteria) Improving cell lines

Sub-cloning

300000 I (pA) 250000 Na

200000 mV -100 -80 -60 -40 -20 20 40 60 80 100 150000

RFU RFU -1000 100000 -2000 50000 Parental Control Parental TTX 100 nM -3000 0 Subclone Control Subclone TTX 100 nM -4000 HEK UT HEK CLONE17 CLONE68 CLONE91 CLONE92 CLONE93 CLONE94 CLONE95 CLONE96 CLONE97 CLONE98 CLONE99

CLONE100 CLONE101 CLONE102 CLONE103 CLONE104 -5000 PARENTAL CLONE Parallel Processing

1 2 3 4 5 6

Fold increase in time Fold increase in cost versus single cell line versus single cell line

0 Molecular Biology 4-fold

Transfection & 0 2-fold selection

0 Colony screening 2-fold

3-fold Functional 6-fold Characterization

<1.5-fold <3-fold Parallel Processing

Development of multiple cell lines in parallel

• Selectivity panels

• Animal variants

• Disease-related mutants

• Mixed selections

Benefits

• Minimal increase in timelines

• Significant cost savings

Assay services

• Flexstation, conventional electrophysiology, IonWorks, QPatch

 High throughput screening  Selectivity profiling  Biophysical characterization  Lead optimization

• DRG studies

• In vivo models of pain DRG studies

Freshly isolated rat DRG

Presence of sodium, calcium, potassium & TRP channels

Potassium currents

6000 1000

4000 0

2000

-1000 0

-2000 Calcium currents Sodium currents

2000

1500

1000 Delayed rectifier currents

500

0 DRG studies

TRPs channels in DRGs cells

100 CurrentCurrentPeakPeak (pA) (pA)

0 Menthol 500 µM AITC 100 µM (TRPM8) Capsaicin 100 µM (TRPV1) (TRPA1)

0 10 20 30 40 50 60 70 80 Voltage Ramps (n) Proof of concept in vivo models of pain

Inflammatory pain (CFA)

• Complete Freund’s adjuvant injected into hind paw • Acute & sub-chronic inflammation at 24hr / 7 days respectively

• Inflammatory cascade causes swelling & pain lasting 1-14 days

• Thermal hyperalgesia (Hargreaves plantar test) & mechanical hypersensitivity (weight bearing) assessed

55.0

** ** 16 * 50.0 ** * ** ** * ** 45.0 ** vehicle 12 * 3 mg/kg 10 mg/kg 40.0 30 mg/kg

8 % weight bearing 35.0 Paw withdrawal latency (s)

4 30.0 Baseline 0 1 3 5 Baseline 0 1 3 5 Time (h) Time (h)

Carrageenan model also available Proof of concept in vivo models of pain

Neuropathic pain (Chung model)

• Tight ligation of the L5 spinal nerve • Mechanical allodynia measured by paw withdrawal threshold (von Frey filaments)

• Thermal hyperalgesia measured by Hargreaves plantar test

Vehicle 4 mg/kg 15.0 *** 10 mg/kg 40 mg/kg

*** *** ** 10.0 ***

**

5.0 Paw Paw thresholdwithdrawal (g)

0.0 Baseline 0 0.5 1 2 3 Time (h)

Bennett (CCI) model also available Proof of concept in vivo models of pain

Post-operative pain (Brennan model)

• Incision made in plantar surface of hind paw, plantaris muscle elevated & wound closed • Causes spontaneous pain, thermal & mechanical thresholds reduced for 4 days • Thermal hyperalgesia (Hargreaves plantar test) & mechanical allodynia paw withdrawal (von Frey filaments) assessed

** 25 ** 15 ** ** **

20 ** ** ** 10 vehicle 15 * 0.3 mg/kg ** 1 mg/kg 3 mg/kg 10 6 mg/kg 5

5 Paw withdrawal latency (s) Paw withdrawal threshold (g)

0 0 Baseline 0 0.5 1 2 Baseline 0 0.5 1 2 Time (h) Time (h) Proof of concept in vivo models of pain

Acute nociception tests

• Measure response thresholds to high intensity stimuli • Hotplate & tailflick tests in response to thermal stimulus in vivo expertise

• In vivo specialists are SB Drug Discovery employees

• All work carried out at SB Drug Discovery’s site

• Scientists possess the relevant animal licences

• Each specialist has >10 years in vivo experience

• SB standard protocols or client specified methods

• All models are validated and ready to run Summary

Extensive panel of off-the-shelf ion channel cell lines

Largest commercial source of TRP channels

Risk -free ion channel cell line development

High throughput screening, profiling & biophysical characterization

DRG studies & in vivo models of pain